Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences Stock Forecast

Stock Price Forecast

The 5 analysts that cover Cytek Biosciences stock have a consensus rating of "Hold" and an average price target of $5.70, which forecasts a 30.73% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $7.50.

Price Target: $5.70 (+30.73%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$3.00	$5.70	$6.00	$7.50
Change	-31.19%	+30.73%	+37.61%	+72.02%

* Price targets were last updated on Jan 8, 2026.

Analyst Ratings

The average analyst rating for Cytek Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	0	0	0	1	1	1
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	4	4	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brendan Smith TD Cowen	TD Cowen	Strong Buy Maintains $4 → $5	Strong Buy	Maintains	$4 → $5	+14.68%	Jan 8, 2026
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $8 → $7.5	Buy	Maintains	$8 → $7.5	+72.02%	Nov 11, 2025
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $9 → $7	Hold	Maintains	$9 → $7	+60.55%	May 28, 2025
Matthew Sykes Goldman Sachs	Goldman Sachs	Strong Sell Maintains $3.5 → $3	Strong Sell	Maintains	$3.5 → $3	-31.19%	May 12, 2025
Mason Carrico Stephens & Co.	Stephens & Co.	Buy Reiterates $6	Buy	Reiterates	$6	+37.61%	Mar 19, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

211.60M

Increased by 5.02%

from 201.49M

Revenue Next Year

228.29M

Increased by 7.89%

from 211.60M

EPS This Year

-0.25

from -0.52

EPS Next Year

-0.20

from -0.25

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	127.95M	164.04M	193.02M	200.45M	201.49M	211.60M	228.29M
Revenue Growth	37.82%	28.20%	17.67%	3.85%	0.52%	5.02%	7.89%
EPS	0.00	0.02	-0.09	-0.05	-0.52	-0.25	-0.20
EPS Growth	-99.36%	2,906.28%	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	219.7M	240.1M
Avg	211.6M	228.3M
Low	200.9M	210.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	9.0%	13.4%
Avg	5.0%	7.9%
Low	-0.3%	-0.6%

EPS Forecast

EPS	2026	2027	2028
High	-0.24	-0.18
Avg	-0.25	-0.20
Low	-0.26	-0.22

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.